EUVIMEDEUVIMED entdecken
Crossref

Ten reasons to use fosfomycin trometamol in daily practice

Paweł Miotła

Medycyna Faktów · 2021

DOI: 10.24292/01.mf.0121.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medycyna Faktów, 2021. Verfasst von Paweł Miotła.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urinary tract infections are one of the most common diseases among women. At least 50% of women will develop at least one of urinary tract infection episode during life-time. It should be also underlined that more than one-fourth of them will also develop recurrence within the half year following the initial infection and therapy. The empirical treatment of urinary tract infections should include susceptibility data based on local antimicrobial resistance rates. The effective initial treatment can be considered as an effective preventive strategy of the rapidly increasing bacterial resistance to antibiotics. Fosfomycin trometamol is a safe and highly effective antimicrobial drug which can be used in a single dose in the treatment of uncomplicated urinary tract infections.

Zitieren

APA

Miotła, P. (2021). Ten reasons to use fosfomycin trometamol in daily practice. Medycyna Faktów. https://doi.org/10.24292/01.mf.0121.11

Vancouver

Miotła P. Ten reasons to use fosfomycin trometamol in daily practice. Medycyna Faktów. 2021. doi:10.24292/01.mf.0121.11

BibTeX
@article{Miota2021,
  author = {Miotła, Paweł},
  title = {Ten reasons to use fosfomycin trometamol in daily practice},
  journal = {Medycyna Faktów},
  year = {2021},
  doi = {10.24292/01.mf.0121.11}
}
Kostenlos starten →